new drug application

2 items

March 6, 2026

First Patient Dosed in Emalex Biosciences’ Expanded Access Program for Investigational Tourette Syndrome Therapy
Study opens pathway to investigational therapy for [...]
February 12, 2026

Biotech Innovation Update
Last year, Paragon Biosciences and [...]